114 related articles for article (PubMed ID: 12021127)
1. BCG vaccination and GAD65 and IA-2 autoantibodies in autoimmune diabetes in southern India.
Sanjeevi CB; Das AK; Shtauvere-Brameus A
Ann N Y Acad Sci; 2002 Apr; 958():293-6. PubMed ID: 12021127
[TBL] [Abstract][Full Text] [Related]
2. GAD65 and ICA512 antibodies in undernourished and normally nourished south Indian patients with diabetes.
Das AK; Shtauvere-Brameus A; Sanjeevi CB
Ann N Y Acad Sci; 2002 Apr; 958():247-50. PubMed ID: 12021116
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune diabetes in 26 villages outside Madras.
Datta M; Shtauvere-Brameus A; Gupta V; Mani MK; Sanjeevi CB
Ann N Y Acad Sci; 2002 Apr; 958():285-8. PubMed ID: 12021125
[TBL] [Abstract][Full Text] [Related]
4. ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India.
Gupta M; Tandon N; Shtauvere-Brameus A; Sanjeevi CB
Ann N Y Acad Sci; 2002 Apr; 958():329-32. PubMed ID: 12021135
[TBL] [Abstract][Full Text] [Related]
5. IA-2 autoantibodies are predominant in latent autoimmune diabetes in adults patients from eastern India.
Kanungo A; Sanjeevi CB
Ann N Y Acad Sci; 2003 Nov; 1005():390-4. PubMed ID: 14679098
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
[TBL] [Abstract][Full Text] [Related]
7. A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
Myers MA; Fenalti G; Gray R; Scealy M; Tong JC; El-Kabbani O; Rowley MJ
Ann N Y Acad Sci; 2003 Nov; 1005():250-2. PubMed ID: 14679070
[TBL] [Abstract][Full Text] [Related]
8. GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes.
Hampe CS; Kockum I; Landin-Olsson M; Törn C; Ortqvist E; Persson B; Rolandsson O; Palmer J; Lernmark A
Diabetes Care; 2002 Aug; 25(8):1481-2. PubMed ID: 12145258
[No Abstract] [Full Text] [Related]
9. Autoantibodies to GAD65 and IA-2 antibodies are increased, but not tissue transglutaminase (TTG-Ab) in type 2 diabetes mellitus (T2DM) patients from South India.
Sanjeevi CB; Balaji M; Balaji V; Seshiah V
Ann N Y Acad Sci; 2003 Nov; 1005():387-9. PubMed ID: 14679097
[TBL] [Abstract][Full Text] [Related]
10. Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?
Shtauvere-Brameus A; Falorni A; Rumba I; Sanjeevi CB
Ann N Y Acad Sci; 2002 Apr; 958():259-62. PubMed ID: 12021119
[TBL] [Abstract][Full Text] [Related]
11. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibodies against GAD, GAD65 and IA-2].
Tsujii S
Nihon Rinsho; 2002 Aug; 60 Suppl 8():395-400. PubMed ID: 12355780
[No Abstract] [Full Text] [Related]
13. [Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes].
Cinek O; Pechová M; Kolousková S; Horká I; Sedláková P; Sumník Z; Snajderová M; Vavrinec J
Cas Lek Cesk; 2000 Sep; 139(19):599-603. PubMed ID: 11192752
[TBL] [Abstract][Full Text] [Related]
14. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
16. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
17. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
18. Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.
Lernmark A
J Clin Invest; 2002 Apr; 109(7):869-70. PubMed ID: 11927613
[No Abstract] [Full Text] [Related]
19. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
